News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Sanofi-Aventis (France) to buy Polish Drugmaker Nepentes for $130.4 Million
May 19, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Economic Times -- Sanofi-Aventis unveiled a further push into emerging markets on Wednesday with plans to buy Polish consumer healthcare group Nepentes in a deal valuing it at around 105 million euros ($130.4 million).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Sanofi
MORE ON THIS TOPIC
Deals
Pfizer pens $500M+ deal with Enodia to destroy disease-causing proteins
October 13, 2026
·
2 min read
·
Tristan Manalac
IPO
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
October 9, 2026
·
3 min read
·
Gabrielle Masson
Deals
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
October 9, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
·
2 min read
·
Nick Paul Taylor